Details for New Drug Application (NDA): 018813
✉ Email this page to a colleague
The generic ingredient in LOTRIMIN is butenafine hydrochloride. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Summary for 018813
Tradename: | LOTRIMIN |
Applicant: | Schering |
Ingredient: | clotrimazole |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018813
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | 1% | ||||
Approval Date: | Feb 17, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 018813
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | LOTRIMIN | clotrimazole | LOTION;TOPICAL | 018813-001 | Feb 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Schering | LOTRIMIN | clotrimazole | LOTION;TOPICAL | 018813-001 | Feb 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Schering | LOTRIMIN | clotrimazole | LOTION;TOPICAL | 018813-001 | Feb 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription